Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain (NCT06872567)

🧪 Interventions in This Study

• genicular artery embolization (DEVICE)
• Corticosteroid Injection (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Virginia — Charlottesville, Virginia

📞 Contact the Study Coordinator

Phone: (646) 369-1570

Email: haskalembo@gmail.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Knee Osteoarthritis (Knee OA)

• Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR) — Toronto, Ontario
• Pilot and Feasibility Study of Anti-CD14 for the Treatment of Knee Osteoarthritis — Philadelphia, Pennsylvania
• Personalized Analgesia Through Central Nervous System Engagement to Unlock Performance — Pittsburgh, Pennsylvania
• Advanced Brain Imaging-TKA (fMRI-TKA) — Ottawa, Ontario

Explore by condition: All Knee Osteoarthritis (Knee OA) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.